Drugs / Modified-Release Prednisone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02506192 | Jul 2015 → Oct 2023 | chronic pain syndrome, cognitive impairment with or without cerebellar ataxia | Minneapolis Veterans Affairs Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Modified-Release Prednisone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02506192 ↗ |
| Route | Oral | “Take oral tablets as directed” NCT02506192 ↗ |